WHITEHOUSE STATION, N.J. (AP) — Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic reactions over time, rather than just relieving sneezing, itching and other symptoms temporarily.
Merck's latest application is for an allergy immunotherapy tablet for ragweed allergies that dissolves under the tongue. Patients in studies of the tablet took it daily for a year.
It could become an alternative to months of uncomfortable allergy shots. Both methods gradually desensitize the immune system to the substance triggering the allergic reaction.
In March, the Whitehouse Station, N.J., company said the FDA was reviewing its application for an immunotherapy tablet for grass pollen allergies.
Merck expects FDA rulings on both still-unnamed treatments in 2014's first half.
'Nailed it': Actor Donnie Wahlberg suggests media are 'very afraid' of Rubio
- What Is Your U.S. Income Percentile Ranking?
Donald Trump: We're Going To Keep Common Core (Updated) | RedState
GM Fires Concealed Carrying Valet Who Saved Autoworker Under Attack
Rush Limbaugh: Ted Cruz is the closest we’ve gotten to Ronald Reagan in our lifetimes
Stephen Self - Clinton Gets More Delegates Than Sanders Despite NH Blowout
New Jersey Man Slays Child | Human Events